Abeona Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company’s development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
/ 
Frequently asked questions
To buy Abeona Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Abeona Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Abeona Therapeutics Inc. is ABEO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Abeona Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade Abeona Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Abeona Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Abeona Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Abeona Therapeutics Inc..